Studies on the effects of heparin products on pregnancy-associated plasma protein A.
Wittfooth S, Tertti R, Lepäntalo M, Porela P, Qin QP, Tynjälä J, Inkinen O, Perttilä J, Airaksinen KE, Pettersson K
Purpose
Conclusion
Studies (1)
Purpose
The purpose of this study was to determine the effects of intravenous and subcutaneous administration of anticoagulants on PAPP-A levels in serum specimens. All specimens were stored at -70 degrees C until analysis.
Summary of Findings
Intravenous administration of LMWH or UFH resulted in a rapid increase in free PAPP-A levels in serum specimens taken 5 or 10 minutes after administration of the anticoagulant, 85% of which was then cleared with a half-life of 13.1 minutes. Subcutaneous administration of LMWH also resulted in a smaller and slower increase in free PAPP-A levels in serum than that observed with intravenous anticoagulant administration. Intravenous bivalirudin and gender had no effects on free PAPP-A. Complexed PAPP-A levels were unaffected by anticoagulants. In acute coronary syndrome patients, the molecular size of free PAPP-A was larger in heparin plasma than in serum. Free PAPP-A extracted from a plaque tissue specimen with LMWH was also found to have a larger molecular size than PAPP-A extracted with sodium chloride. Further, recombinant PAPP-A diluted in serum with LMWH or in heparin plasma had a larger molecular size than recombinant PAPP-A in serum with no LMWH.
Biospecimens
FluidSerumFluidPlasmaTissueBlood VesselFluidBloodPreservation Types
FrozenDiagnoses
Cardiovascular DiseaseCoronary Artery DiseaseOther diagnosesNormalPlatforms
ProteinImmunoassayProteinSize-exclusion chromatographyPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Diagnosis/ patient condition Abdominal aortic aneurysmAcute coronary syndromeAtherosclerosisCerebrovascular attackHaemodialysis patientInfectionMultiple traumaVascular surgeryPreaquisition Other drugs Intravenous bivalirudinIntravenous low molecular weight heparinIntravenous unfractionated heparinSubcutaneous low molecular weight heparinPreaquisition Patient gender FemaleMaleBiospecimen Acquisition Biospecimen location Plaque tissuePlasmaSerumBiospecimen Acquisition Time of biospecimen collection 1 h prior to administration10 min post administration12 h post administration15 min post administration2 h post administration30 min post administration4 h post administration40 min post administration5 min post administration6 h post administration60 min post administration70 min post administrationTime 0Biospecimen Aliquots and Components Blood and blood products PlasmaSerum